Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Prediction: This Stock Could Double By 2031

TheMotleyFool

0 0

Prediction: This Stock Could Double By 2031Photo, wide shot, wide-angle lens, Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png

Exelixis (NASDAQ: EXEL) has been a solid stock to own over the past five years, with its shares climbing 101%, slightly beating out the S 500. The good news is that there is plenty of upside left for the biotech company. Over the next five years, the drugmaker could, once again, achieve 2-bagger status (that is, a stock that delivers 100% returns). Here is why.